Navigation Links
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Date:11/9/2007

ear 1 and maintained at Year 5.

The safety analysis represents five years of cumulative data. This includes all patients who received at least one dose of ORENCIA during the one-year double-blind period and all patients who entered the open-label period who received at least one dose of ORENCIA plus all patients randomized to receive placebo (n=287). The incidence rates observed during the five-year cumulative period for serious adverse events (SAEs), infections, serious infections, malignancies and autoimmune events were consistent with both the double-blind period and the integrated safety summary, which is comprised of seven core RA studies representing approximately 8,400 patient years of exposure. The incidence rates for SAEs in the double-blind period, five-year cumulative period and the integrated safety summary were 20/100 pt-years, 18.9/100 pt-yrs and 15.4/100 pt-yrs, respectively. The incidence rates for infections in the double-blind period, five-year cumulative period and the integrated safety summary were 94.2/100 pt-years, 77.3/100 pt-yrs and 79.2/100 pt-yrs, respectively. The incidence rates for serious infections in the double-blind period, five-year cumulative period and the integrated safety summary were 2.1/100 pt-years, 3.0/100 pt-yrs and 3.0/100 pt-yrs, respectively. The incidence rates for malignancies in the double-blind period, five-year cumulative period and the integrated safety summary were 2.1/100 pt- years, 1.5/100 pt-yrs and 1.3/100 pt-yrs, respectively. A total of 12 autoimmune disorders, the most frequent of which were psoriasis and cutaneous vasculitis, were reported in 12 patients in the cumulative study period.

During the five-year cumulative period, 32 patients (11.1 percent) discontinued due to SAEs. A total of five deaths occurred through five years of the study; all were considered to be unlikely related or unrelated to study medication.

About ORENCIA(R) (abatacept)

ORENCIA is indicated in the United Sta
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
6. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
9. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
11. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...   Life Line Screening  (LLS), a leading ... creation of a unique partnership with MCM Solutions ... is a population health management organization. LLS will provide ... These important expanded services will help MCM and its ... reduces cost of care when individuals are able to ...
(Date:5/22/2013)... 2013  Flagship Ventures, a leading venture capital ... sustainability, today announced the appointment of ... In this role, Mr. Bancel will provide strategic ... In addition to working closely with companies in ... President and Chief Executive Officer of Moderna Therapeutics, ...
(Date:5/22/2013)... NEW YORK , May 22, 2013  Ohr ... the development of novel therapeutics for unmet medical needs, ... Almenoff , M.D., Ph.D., to its Board of ... industry, working on early and late stage drug development. ... Almenoff join Ohr,s Board," said Dr. Irach Taraporewala, CEO ...
Breaking Medicine Technology:Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... 2011 Argos Therapeutics, Inc. today announced that its late ... awarded the Nobel Prize in medicine for the discovery of ... Dr. Steinman,s discovery of dendritic cells and his research ... in adaptive immunity have led to the development of Argos, ...
... 4, 2011 Ingenious Med welcomes Chief Financial Officer, ... Adams will be responsible for the company,s financial, accounting, ... is an experienced executive with high growth companies such ... Med.  "His extensive financial background and experience will bring ...
Cached Medicine Technology:Argos Therapeutics' Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System 2New Chief Financial Officer, Mark Adams, Joins Ingenious Med 2
(Date:5/22/2013)... Thompson HealthDay Reporter , , WEDNESDAY, May 22 ... back pain are more likely to attempt suicide, whether ... psychiatric condition, according to a new study. "Clinicians ... be aware they are at increased risk of suicide," ... Serious Mental Illness Treatment Resource and Evaluation Center in ...
(Date:5/22/2013)... Cedar Rapids, IA (PRWEB) May 22, 2013 ... inspirational theatre piece Handicap This! The performance promotes ... pursuing their dreams. The Handicap This! performance will be ... Linn Mar High School auditorium. Tickets for Handicap ... , Handicap This! helps audiences measure the level to ...
(Date:5/22/2013)... in genomic health disparities from the University of Miami ... of Medicine have teamed up to hold the second ... Disparities in Genomic Medicine." The theme of this ... and government to reduce these disparities. , Despite steady ... individuals within underserved groups continue to be more vulnerable ...
(Date:5/22/2013)... Hollow, New York (PRWEB) May 22, 2013 ... York, has established the Westchester Lung Nodule Center ... nodules or receive lung cancer care. Lung cancer is the ... Each year, more people in the U.S. die from lung ... , As with all cancers, early detection increases survival rates. ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Finding trustworthy, loving ... parents can do for their children. To help parents in ... chock-full of information about their nurturing programs, staff and ... captures the warm spirit of Paty’s Daycare,” said Patricia “Auntie ... feel welcome when you visit the new website, from the ...
Breaking Medicine News(10 mins):Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:Handicap This! Comes to Marion, Iowa 2Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2
... , Including Tips to Help Prevent the Spread of ... right around the corner, and H1N1 flu widespread across the ... and children celebrate safely this year. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ... trick-or-treating and come home sick," said Sharon Stanley, Chief Nurse ...
... of a consultation room can improve the quality of ... study developed by Nurture by Steelcase and Mayo Clinic, ... consultation room designed to support present-day clinical encounters could ... of this randomized trial, the first of its kind, ...
... Even though no-one wants to admit it,the countdown to Christmas is upon ... then follow the realbuzz.com guide to a healthier,you. You know that once ... so now,s the time to turn your body into a temple. , ... didn,t offer this piece of,advice to start with! If you don,t already ...
... ... Companies, Families and Communities in Tri-State Area , ... Pittsburgh, P.A. (PRWEB) October 28, 2009 ... compensation facility in Western Pennsylvania, this week unveiled the new AlleghenyMedical.com--a one-stop destination ...
... ... Diabetes Patients to Reduce Hospital Readmission , ... Atlanta, Georgia (PRWEB) October 28, 2009 -- The IN Compass ... Quality Award for the team,s project "Indigent Diabetic Patient Follow-Up Care Program" at the ...
... ... medicine and recently demonstrated its technology by creating three free e-books on H1N1 ... to empower e-patients and technologically enable participatory medicine. , ... Los Altos, CA (PRWEB) October ...
Cached Medicine News:Health News:Red Cross Offers the 'Trick' to Safety this Halloween 2Health News:Researchers find room design can enhance patient care 2Health News:The Countdown to Christmas - The realbuzz.com Guide to a Healthier You! 2Health News:Allegheny Medical Announces Launch of the New AlleghenyMedical.com 2Health News:Allegheny Medical Announces Launch of the New AlleghenyMedical.com 3Health News:IN Compass Health's Hospitalist Team at Morton Plant Wins First BayCare Quality Award 2Health News:IN Compass Health's Hospitalist Team at Morton Plant Wins First BayCare Quality Award 3Health News:IN Compass Health's Hospitalist Team at Morton Plant Wins First BayCare Quality Award 4Health News:Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 2Health News:Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 3
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: